Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study

Keyphrases

• Population-based Study 100%
• Clinical Effect 100%
• Breast Cancer Treatment 100%
• Electronic Patient-reported Outcome (ePRO) 100%
• Symptomatic Toxicity 100%
• Treatment Adjustment 40%
• Breast Cancer 20%
• Active Treatment 20%
• Health Systems 20%
• Usual Care 20%
• Trial Registration 20%
• Treatment Setting 20%
• Adjuvant Chemotherapy 20%
• Cancer Patients 20%
• Cluster Randomized Trial 20%
• Number of Events 20%
• Public Health System 20%
• Febrile Neutropenia 20%
• Symptom Reporting 20%
• Oncology Department 20%
• Cultural Narratives 20%
• Lack of Evidence 20%
• Hospitalization Rate 20%

Medicine and Dentistry

• Cancer Therapy 100%
• Breast Cancer 100%
• Patient-Reported Outcome 100%
• Arm 40%
• Health Care 20%
• Health System 20%
• Malignant Neoplasm 20%
• Public Health 20%
• Oncology 20%
• Febrile Neutropenia 20%
• Cluster Randomized Trial 20%
• Adjuvant Chemotherapy 20%
• Narrative 20%
• Active Treatment 20%

Nursing and Health Professions

• Breast Cancer 100%
• Patient-Reported Outcome 100%
• Cancer Therapy 100%
• Malignant Neoplasm 20%
• Healthcare System 20%
• Febrile Neutropenia 20%
• Adjuvant Chemotherapy 20%
• Public Health Service 20%